Dexmedetomidine as rescue drug during awake craniotomy for cortical motor mapping and tumor resection.
Dexmedetomidine, approved for providing sedation in the critical care environment, is also used during awake craniotomies to facilitate procedures such as cortical mapping. Herein, we describe the use of dexmedetomidine as a rescue drug during awake craniotomy avoiding conversion to general anesthesia, thus allowing completion of cortical mapping.
Moore
Thomas A
TA
Department of Anesthesiology, University of Alabama School of Medicine, Birmingham, Alabama 35249-6810, USA. tamoore@uab.edu
Markert
James M
JM
Knowlton
Robert C
RC
D001931:Brain Mapping / Q000379:methods*; D001932:Brain Neoplasms / Q000188:drug therapy / Q000601:surgery*; D002540:Cerebral Cortex / Q000187:drug effects / Q000502:physiology; D003399:Craniotomy / Q000379:methods*; D020927:Dexmedetomidine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D016343:Monitoring, Intraoperative / Q000379:methods; D014851:Wakefulness / Q000502:physiology
D020927:Dexmedetomidine